In Vitro Fertilization Market Growth & Trends

The global in vitro fertilization market size is expected to reach USD 37.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.9% from 2022 to 2030. The market is driven by the continuous efforts of the market players, government initiatives to make available better reimbursement policies, and an increase in the incidence of infertility due to lifestyle changes. Expansion of fertility procedures such as ICSI for treating infertility is expected to positively impact the market growth in the near future.

Moreover, the availability of genomic testing facilities that enable the prevention of the transfer of genetic disorders during In Vitro Fertilization (IVF) is further expected to drive the IVF market. The insurance providers are providing coverage for IVF procedures owing to an increase in the number of IVF treatments. This has led to competitive pricing and has moderated the IVF treatment costs as the procedure has been a successfully practiced technology, driving the market with more treatment automation and standardization.

A decline in the Total Fertility Rate (TFR) is a result of factors such as a behavioral shift in society. These factors include a shift from rural to urban societies, the increased age of the first birth, postponement of marriage, an increasing number of women employees, and lower marriage rates. In March 2020, the in-person fertility treatments in U.S. and Canada were suspended due to the COVID-19by the American Society of Reproductive Medicine and Canadian Fertility and Andrology Society. However, treatment is resuming in many countries with the ease of COVID-19 restrictions. The research findings published by the Obstetrics and Gynecology journal, in January 2022 reported COVID-19 vaccines won’t harm IVF outcomes. This is expected to prove significant in promoting the uptake of IVF in eligible vaccinated individuals.

Request a free sample copy or view the report summary: 
In Vitro Fertilization Market Report

In Vitro Fertilization Market Report Highlights

• The culture media segment dominated the market in terms of revenue in 2021. A number of research activities are being undertaken to improve the efficiency of cultural media. For instance, Vitrolife showcased its research on SpermFreeze solution at the American Society for Reproductive Medicine (ASRM) that established the effectiveness of its solution for sperm recovery and sperm-hyaluronic acid-binding
• Europe dominated the market for procedures and instruments in 2021. Adoption of advanced technologies such as time-lapse microscopy by the clinics, availability of affordable treatment, and adherence to medical standards contribute to its market dominance
• In APAC, the market is expected to witness increased demand for IVF owing to fertility tourism and the availability of funding for the treatment. In Japan, eligible couples can apply for co-funding for a maximum of three cycles with USD 1,920 for each cycle
• The developing countries in the Asia Pacific region are undertaking legal reforms to promote treatment adoption in the region. For instance, in February 2020, the Government of India approved a bill for the regulation of clinics offering reproduction assistance services, including IVF, artificial insemination, and surrogacy
• In January 2020, Merck received Marketing Authorization (MA) from the European Commission (EC) for its recombinant human follicle-stimulating hormone, GONAL-f (follitropin alfa) 150 IU pen